Dicot Pharma Receives Patent for LIB-01 Manufacturing Process in 25 European Countries
Bitget2026/10/26 08:05Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Dicot Pharma has been granted a patent in 25 European countries covering the manufacturing process for its drug candidate LIB-01.
- The patent provides protection until 2043, complementing existing patents for the erectile dysfunction and premature ejaculation treatment.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dicot Pharma AB published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Updated: Wendy's rejected the $1.4 billion acquisition offer led by Trian
路透社•2026/11/05 12:21
BUZZ-Cigna shares rise after raising annual profit forecast
路透社•2026/11/05 12:14
Crypto prices
More
Bitcoin
BTC
$80,069.02
+2.76%
Ethereum
ETH
$2,410.95
+4.43%
Tether USDt
USDT
$0.9989
+0.02%
BNB
BNB
$713.6
+2.08%
XRP
XRP
$1.31
+2.64%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$96.09
+3.69%
TRON
TRX
$0.3183
-0.13%
Zcash
ZEC
$1,313.77
+2.83%
Hyperliquid
HYPE
$82.06
-3.72%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now